{"id":"W3128034858","doi":"10.1016/s0140-6736(21)00126-4","title":"Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial","year":2021,"lang":"en","type":"article","venue":"The Lancet","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":284,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University","funders":"UCB Pharma","keywords":"Medicine; Placebo; Psoriasis; Population; Dosing; Clinical trial; Psoriasis Area and Severity Index; Adverse effect; Internal medicine; Clinical endpoint; Randomized controlled trial; Tolerability; Plaque psoriasis; Physical therapy; Dermatology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007177826,0.0003394466,0.001252659,0.0001007947,0.0002723704,0.00006610219,0.0002572162,0.00025932,0.0003087373],"category_scores_gemma":[0.0002123596,0.0002281105,0.0001349131,0.0002494942,0.00008084875,0.00008580892,0.0001004111,0.0002926937,0.0001412638],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006357722,"about_ca_system_score_gemma":0.0001543572,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000113541,"about_ca_topic_score_gemma":0.0005181209,"domain_scores_codex":[0.9974658,0.0008685233,0.0005172929,0.0005067902,0.00006924744,0.0005723727],"domain_scores_gemma":[0.998123,0.001023337,0.0001447661,0.0005802661,0.00006815964,0.00006044235],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9818525,0.0006262511,0.00004581569,0.00001273264,0.000847896,0.00006944247,0.001675767,0.000144387,0.004819009,0.0002459487,0.001739946,0.007920302],"study_design_scores_gemma":[0.9810914,0.0003223764,0.0001044738,0.00004785724,0.0004179659,0.00007322634,0.0002323781,0.00006535356,0.009459058,0.00004036011,0.007859576,0.0002859809],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9886853,0.001947067,0.00004523412,0.00302696,0.0008331346,0.003395784,0.0002117517,0.0000749349,0.001779803],"genre_scores_gemma":[0.9941337,0.0006113636,0.0001684929,0.0005774579,0.0004599862,0.0005690997,0.0003564498,0.00003106585,0.003092441],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007634321,"threshold_uncertainty_score":0.9302077,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03975210694711809,"score_gpt":0.2980524278399601,"score_spread":0.2583003208928419,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}